Skip to main content
Symptom Management Overview
Identification, Significance, and Management of Complement Inhibitor–Induced Headaches in Patients With Paroxysmal Nocturnal Hemoglobinuria
Lindsey Fold, PharmD; Nina Inayan, PharmD; Justin Arnall, PharmD, BCOP, FCCP
Read More
Online First
Case Reports, Adverse Events, Chemotherapy
Irinotecan-Induced Hypertonia: A Case Report
Vallabhi Mishra, PharmD; Krutika Gohil, MBBS; Alyssa Tian Gu, BS Candidate; Alexandra Zhikharev, BS Candidate; Minaxi Jhawer, MD
Read More
Clinical Trials
AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small Cell Lung Cancer
Read More
Online First
Original Research, Chemotherapy
Financial Effect of Automated Chemotherapy Dose Rounding at an Academic Medical Center
Keeyan Davis, PharmD; Junyu Matt Zhang, PharmD, BCOP, BCPS; Katherine Moser, PharmD, BCPS
Read More
HOPA Corner
DLL3-Targeting BiTE Therapy in SCLC: A Pharmacist’s Guide to Evidence and Integration
Read More
HOPA Corner
Checkpoint Inhibitors: Changing Colorectal Cancer Treatment
Read More
Clinical Trials
The Evolution of Abemaciclib Clinical Trial Data for the Treatment of HR-Positive/HER2-Negative Metastatic Breast Cancer
Read More
HOPA Corner
505(b)(2) Drugs: New Chaos for Infusion Centers
Read More
HOPA Corner, Disparities in Oncology Care
The Crossroad of Social Determinants of Health and Inequalities in Hematologic Malignancies
By Cara Guglielmon
Read More
HOPA Corner
Embracing Equity: The Evolving Role of HOPA in Advancing Fairness, Access, and Representation
Read More
Page 11 of 197
Results 101 - 110 of 1963